Dym - dymeclin Gene
Also Known as RGD1309111
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 291433
Summary
Predicted to enable enzyme binding activity. Predicted to be involved in Golgi organization and bone development. Predicted to be located in cytoplasm. Predicted to be active in Golgi apparatus. Human ortholog(s) of this gene implicated in Dyggve-Melchior-Clausen disease; Smith-McCort dysplasia; and osteochondrodysplasia. Orthologous to human DYM (dymeclin). [provided by Alliance of Genome Resources, Apr 2022]
Dym Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001106133.2 | NP_001099603.2 | dymeclin |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
dymeclin |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-132583A | IONIS-DNM2-2.5Rx sodium | 97.46% | Unkown | |
| HY-132583 | IONIS-DNM2-2.5Rx | / | Unkown | |
| HY-RS04080 | DYM Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17440 | Dym Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23896 | Dym Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service